Effects of Semaglutide on CKD in Patients With Type 2 Diabetes

Effects of Semaglutide on CKD in Patients With Type 2 Diabetes

Saved in:

Bibliographic Details
Main Authors:	Sradha S. Kotwal, Vlado Perkovic
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924033874
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Barriers to Care: New Medications and CKD
by: Dana Kim, et al.
Published: (2024-03-01)

WCN25-1900 Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial
by: Katherine Tuttle, et al.
Published: (2025-02-01)

Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD
by: Bernard Chan, et al.
Published: (2025-04-01)

Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes
by: Jorge Rico-Fontalvo, et al.
Published: (2024-07-01)

Oral semaglutide: the innovation in type 2 diabetes management
by: M. V. Shestakova, et al.
Published: (2021-09-01)

Comparative cardiovascular outcomes of semaglutide to dulaglutide in patients with type 2 diabetes
by: Takefumi Kishimori, et al.
Published: (2025-07-01)

Effects of Semaglutide and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice
by: Fang Lv, et al.
Published: (2024-12-01)

Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands
by: Barnaby Hunt, et al.
Published: (2019-05-01)

Real‐World Persistence and Characteristics of Type 2 Diabetes Patients Prescribed Semaglutide in Scotland
by: David Alexander Dickie, et al.
Published: (2025-05-01)

Semaglutide ameliorates diabetes-associated cognitive dysfunction in mouse model of type 2 diabetes
by: Yan Zhu, et al.
Published: (2025-01-01)

Effectiveness for adding or switching from other incretin‐related drugs to oral semaglutide in type 2 diabetes
by: Junko Oya, et al.
Published: (2025-04-01)

Recommendations for Titration and Administration of Oral Semaglutide for the Treatment of Type 2 Diabetes during Ramadan
by: Mohamed Hassanein, et al.
Published: (2022-12-01)

Effect of semaglutide on arrhythmic, major cardiovascular, and microvascular outcomes in patients with type 2 diabetes: a systematic review and meta-analysis
by: Rui Wu, et al.
Published: (2025-08-01)

Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial
by: Jelena Petković-Dabić, et al.
Published: (2025-01-01)

Subclinical Changes in Type 2 Diabetes Patients with Heart Failure Stage A and B Treated with Oral Semaglutide
by: Larissa Dăniluc, et al.
Published: (2025-03-01)

Race of GLPS: Impact on Weight and Glycemic Control on Type 2 Diabetes with Semaglutide Versus Liraglutide
by: Noha Hafeez, et al.
Published: (2024-12-01)

Finerenone and Estimated GFR Slope in Type 2 Diabetes and CKD
by: Masayuki Yamanouchi, et al.
Published: (2025-07-01)

Efficacy and safety of oral semaglutide in Russian patients with type 2 diabetes: subgroup analysis of PIONEER 1, 2, 3 trials
by: M. Sh. Shamkhalova, et al.
Published: (2022-07-01)

Cardiovascular Outcomes of Semaglutide vs Dulaglutide in Nonobese Type II Diabetes Patients With HFpEF
by: Patrick A. Kwaah, MBChB, et al.
Published: (2025-07-01)

Association of semaglutide use with depressive symptoms and suicidal behavior in a patient with type 2 diabetes: A case report
by: Anisija Stojkovska, et al.
Published: (2025-07-01)

Semaglutide in people with obesity and type 2 diabetes on hemodialysis: a prospective analysis of glycemic and weight outcomes
by: Akinori Hayashi, et al.
Published: (2025-05-01)

Insights into the Efficacy of GLP-1 Agonists and Dual Agonists: Semaglutide and Tirzepatide in Obesity and Type 2 Diabetes
by: Laura Opalska, et al.
Published: (2024-12-01)

Semaglutide and the Retina
by: Zachary T. Bloomgarden
Published: (2025-04-01)

Tirzepatide Versus Semaglutide on Weight Loss in Type 2 Diabetes Patients: A Systematic Review and Meta‐Analysis of Direct Comparative Studies
by: Jimmy Wen, et al.
Published: (2025-05-01)

The impact of oral semaglutide on glycemic control and weight reduction: a database analysis of dosing effects in Japanese individuals with type 2 diabetes
by: Mizuki Ishiguro, et al.
Published: (2025-08-01)

Semaglutide and High-Intensity Interval Exercise Attenuate Cognitive Impairment in Type 2 Diabetic Mice via BDNF Modulation
by: Sijie Lai, et al.
Published: (2025-05-01)

Semaglutide Therapy and Accelerated Sarcopenia in Older Adults with Type 2 Diabetes: A 24-Month Retrospective Cohort Study
by: Ren Q, et al.
Published: (2025-07-01)

Weight Loss Effects of Once-Weekly Semaglutide 2.4 mg in Adults with and Without Type 2 Diabetes: A Systematic Review and Meta-Analysis
by: Boram Hong, et al.
Published: (2025-07-01)

Contractile Effects of Semaglutide in the Human Atrium
by: Joachim Neumann, et al.
Published: (2024-08-01)

WCN25-1572 DESIGN AND BASELINE CHARACTERISTICS OF THE GLOBAL KIDNEY PATIENT TRIALS NETWORK
by: Sradha Kotwal, et al.
Published: (2025-02-01)

From Diabetes to Weight Loss: The Problems with Semaglutide's Expanded Use
by: Rawan Othman
Published: (2025-08-01)

Real-World Effectiveness of Oral Semaglutide in Indian Adult Diabetic Patients: Evaluation of EMR-based Data
by: Sandeep Gudibanda, et al.
Published: (2024-10-01)

Corrigendum to “Safety and efficacy of semaglutide in post kidney transplants patients with type 2 diabetes or post-transplant diabetes” [J. Clin. Translat. Endoc. 36C (2024) 100343]
by: Moeber Mohammed Mahzari, et al.
Published: (2024-12-01)

Correlation between mean platelet volume and bone mineral density in type 2 diabetes patients with CKD stage 1-2
by: Mao Rui-kui, et al.
Published: (2021-01-01)

An assessment of treatment satisfaction, adverse effects, cost of treatment among patients with type 2 diabetes for semaglutide when compared to liraglutide: a hospital-based cross-sectional study
by: Sakshi Pandey, et al.
Published: (2025-03-01)

Semaglutide Inducing Resolution of Proliferative Diabetic Retinopathy: A Case Report
by: Daniel Cool, et al.
Published: (2024-01-01)

Semaglutide Ameliorates Diabetic Neuropathic Pain by Inhibiting Neuroinflammation in the Spinal Cord
by: Sing-Ong Lee, et al.
Published: (2024-11-01)

Real-World HbA1c Changes Among Type 2 Diabetes Mellitus Patients Initiating Treatment With a 1.0 Mg Weekly Dose of Semaglutide for Diabetes
by: Noelle N. Gronroos, et al.
Published: (2024-11-01)

SEMAGLUTIDE: Weight loss, glycaemic control and safety profile in obese patients with and without type-II diabetes-An experience from Karachi, Pakistan
by: Muhammad Y. Memon, et al.
Published: (2024-10-01)

Semaglutide therapy and iatrogenic thyrotoxicosis
by: Maxim John Levy Barnett, et al.
Published: (2025-07-01)